Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AdVhAFP
- Development stage
- Phase 1
- Lead developer
- University of Pittsburgh
- Modality
- Vaccines & Immunotherapeutics, Gene Therapies
- Administration
- Intradermal, Subcutaneous, Ex Vivo
01
Overview
AdVhAFP is a recombinant, replication-deficient adenoviral vector engineered to express the human alpha-fetoprotein (AFP) gene. It is designed as an immunotherapy for hepatocellular carcinoma (HCC), a malignancy that frequently overexpresses AFP as a tumor-associated antigen. The vector is primarily used to transduce dendritic cells (DCs) ex vivo or administered directly to induce and expand AFP-specific CD4+ helper and CD8+ cytotoxic T-cell responses. By utilizing an adenoviral delivery system, the therapy aims to overcome immunological tolerance to AFP, which is a self-antigen, thereby promoting a robust Th1-skewed immune response capable of recognizing and eliminating AFP-positive tumor cells.
- Other names
- AFP-expressing adenovirusAdenovirus-hAFPhAFP-adenovirus
02
Targets
AFP (Alpha-fetoprotein)
Beyond the preview
Go deeper on AdVhAFP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AdVhAFP.